CliffBio
small molecule

HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%

HEPARIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameHEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%
Active ingredientHEPARIN SODIUM
Strength40 UNITS/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2017
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.